NAVELLIER & ASSOCIATES INC - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 265 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 2.04 and the average weighting 0.2%.

Quarter-by-quarter ownership
NAVELLIER & ASSOCIATES INC ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2020$269,000
-30.3%
3,7000.0%0.06%
+1.6%
Q4 2019$386,000
-6.5%
3,700
-10.7%
0.06%
-8.8%
Q3 2019$413,000
-11.9%
4,145
+1.0%
0.07%
-5.6%
Q2 2019$469,000
-9.1%
4,1050.0%0.07%
-10.0%
Q1 2019$516,000
-7.9%
4,105
-0.5%
0.08%
-15.8%
Q4 2018$560,000
-83.3%
4,125
-66.2%
0.10%
-78.1%
Q3 2018$3,346,000
+64.0%
12,191
+23.8%
0.43%
+52.5%
Q2 2018$2,040,000
+36.6%
9,849
+8.9%
0.28%
+25.7%
Q1 2018$1,493,000
+163.3%
9,041
+118.4%
0.23%
+113.2%
Q4 2017$567,000
+12.7%
4,1400.0%0.11%
+41.3%
Q2 2017$503,000
-1.2%
4,140
-13.8%
0.08%
+1.4%
Q1 2017$509,000
-56.3%
4,805
-58.1%
0.07%
-61.7%
Q4 2016$1,165,000
+13.8%
11,462
+14.3%
0.19%
+32.2%
Q3 2016$1,024,000
+70.7%
10,029
+99.3%
0.15%
+62.2%
Q2 2016$600,000
-2.8%
5,032
-12.6%
0.09%
+12.5%
Q1 2016$617,000
-40.9%
5,758
-40.2%
0.08%
-30.4%
Q4 2015$1,044,000
+186.8%
9,627
+126.3%
0.12%
+210.8%
Q3 2015$364,000
-46.0%
4,254
-60.7%
0.04%
+23.3%
Q2 2014$674,000
-38.0%
10,824
-33.0%
0.03%
-41.2%
Q1 2014$1,087,000
-16.7%
16,166
-34.8%
0.05%
-13.6%
Q4 2013$1,305,00024,8120.06%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Knott David M Jr 115,000$12,937,0004.12%
Stonepine Capital Management, LLC 73,700$8,291,0003.44%
VILLERE ST DENIS J & CO LLC 510,843$57,464,0003.41%
Chicago Capital, LLC 491,717$55,313,0002.38%
Orchard Capital Management, LLC 73,596$8,279,0002.35%
RICE HALL JAMES & ASSOCIATES, LLC 344,969$38,806,0001.55%
Smith, Graham & Co., Investment Advisors, LP 86,834$9,768,0001.02%
WOODSTOCK CORP 64,050$7,205,0000.84%
INVESTMENT MANAGEMENT OF VIRGINIA LLC 37,246$4,190,0000.74%
Stephens Investment Management Group LLC 417,670$46,984,0000.69%
View complete list of LIGAND PHARMACEUTICALS INC shareholders